Multaq 400 MG tablet 60S

Ended Awarded Last action

Contract number
SPE2DR26F1T99
Awardee
Awarding agency
Obligated
$16,382

Award facts

Contract value 100% obligated
$16,381.64 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a $16,381.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, with an ultimate completion date of January 12, 2026. This non-competitive award was issued on January 9, 2026, with performance of work to be completed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical extending through December 2031. This IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide.

AmerisourceBergen functions as a critical pharmaceutical distributor and healthcare solutions provider serving federal medical procurement needs, particularly for military and veteran healthcare systems. The Multaq (dronedarone) tablets being procured under this delivery order are antiarrhythmic medications used in cardiac care, consistent with the broad therapeutic range of pharmaceutical products the company supplies through its DLA contracts. As a major national pharmaceutical distributor registered in the System for Award Management, AmerisourceBergen regularly fulfills federal medical supply requirements through open competition and demonstrates capability across multiple therapeutic domains supporting Department of Defense and other government healthcare systems.

Quick answers

Who was awarded contract SPE2DR26F1T99?

SPE2DR26F1T99 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.

How much is contract SPE2DR26F1T99 worth?

The government has obligated $16,382 on SPE2DR26F1T99.

Is contract SPE2DR26F1T99 an order under another contract?

Yes. SPE2DR26F1T99 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.

Was contract SPE2DR26F1T99 competed?

The extent of competition for SPE2DR26F1T99 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award